Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
retinal pigment epithelial cells (2 trials)
Blindness (Phase 1)
Leber Congenital Amaurosis (Phase 1)
Retinitis (Phase 1)
Retinitis Pigmentosa (Phase 1)
Trials (2 total)
Trial APIs (1 total)